For UK adults, smoking cessation is the #1 reason for vaping per ASH 2024 annual survey data. ASH 2024 outcome: “the main reasons for vaping are to quit, reduce, or remain abstinent from smoking. The majority of adults who have quit smoking in Great Britain used a vape.” Of an estimated 4.7 million UK vapers (some HMRC estimates suggest 5.4 million), the substantial majority are current or former smokers who started vape to quit or reduce smoking. ASH 2024: nearly 3 million UK smokers have successfully quit using vape over the past 5 years.

Secondary adult reasons per ASH 2024 and the Behavioural Insights Team (BIT) 2025 analysis: saving money (vape ~£125 quarterly vs smoking ~£525 quarterly per Cancer Research UK); perceived lower harm than cigarettes (~45% of UK young adults accurately identify vape as less harmful than smoking per UCL research); social acceptability (vape allowed in more spaces than smoking, even where indoor smoking is banned); flavour enjoyment (variety of e-liquid flavours beyond tobacco); ability to control nicotine dosage and step down; less odour/smell impact on family and clothes; perceived stress management (though this is largely withdrawal cycling rather than true stress relief).

For UK youth (11-17 year olds), motivations differ significantly. Per ASH UK 2025 youth survey: curiosity is the #1 reason for trying vape; friend/family vape availability and peer influence are major factors; perceived lower harm and “everyone is doing it” social pressure; flavour appeal (sweet, fruit, dessert flavours specifically targeted at youth before UK restrictions); easy access through disposable vape products before the June 2025 ban; nicotine addiction once established maintains use. The London School of Hygiene & Tropical Medicine 2025 review found teenagers who start vaping are around 3x more likely to subsequently smoke tobacco. UK government concern about youth vaping drove the June 2025 disposable vape ban and the 2027 generation-based tobacco sale ban (anyone born from 1 January 2009).

The UK adult cessation use case: how vape became the leading quit aid

The UK adult cessation story is the major public health success of vape. Timeline: vape mass-market in UK from ~2010, NHS Stop Smoking Services initially cautious; 2015 PHE 95% safer review changed UK official position; 2016 TRPR implemented regulatory framework; 2019 NHS guidance increasingly positive about vape; 2023 “Swap to Stop” scheme launched aiming for 1 million free vape starter packs; 2024 ASH data showing ~3M quitters in 5 years. The mechanism: vape mimics smoking ritual (hand-to-mouth, throat hit, exhaled vapour) and pharmacology (rapid nicotine delivery 7-10 seconds) better than NRT. Cochrane systematic reviews consistently confirm vape ~2x more effective than NRT for smoking cessation. UK Royal College of Physicians 2024 evidence review: vape is “an effective tool for smoking cessation” and “the most popular UK stop smoking aid.” The Behavioural Insights Team 2025 analysis of UK smoker motivations found: saving money is the top motivator to quit (both smokers and vapers); 50% of UK smokers are NOT motivated to quit for health alone (suggesting cost messaging may work better); intention to quit is critical predictor of cessation success. NHS Stop Smoking Services now actively recommend vape as quit aid for most smokers, particularly those with previous quit attempt failures via NRT alone. The success rate: ASH 2024 – almost two-thirds of UK smokers using vape with NHS Stop Smoking support successfully quit smoking.

The UK youth use case: a different and more concerning picture

UK youth vape motivations differ fundamentally from adult motivations and present different public health concerns. ASH 2025 UK youth survey: 18% of 11-17 year olds have tried vape; 7% currently vape (4% regularly, 3% occasionally); 20% have tried at some point. These rates were stable in 2024-2025 after sharp increases 2021-2023. The 2021-2023 spike was driven by disposable vape availability with appealing flavours, packaging and marketing. UK government response: June 2025 disposable vape ban (also environmental rationale); 2027 tobacco generation-based ban; restrictions on vape flavours, packaging and promotion to be implemented; retail licensing scheme; advertising and sponsorship ban; vape vending machines ban; new October 2026 Vaping Products Duty (tax). Youth vape motivations: curiosity (try it once, may or may not continue); peer influence (friends vape); perceived lower harm (less smell, “less bad” than smoking); flavour appeal; nicotine addiction once dependent; social and identity factors (image, belonging). Significant concern: LSHTM 2025 review showed UK teenagers who start vape are around 3x more likely to subsequently start tobacco smoking. Vape may therefore act as a “gateway” to smoking for some youth, undermining the adult cessation success story. UK Tobacco and Vapes Bill includes specific measures targeting youth uptake while protecting adult cessation use. Our Omagh and Strabane stores follow strict UK age verification: legal sales only to 18+ with photographic ID for any customer appearing under 25. Any sale to under-18s is illegal and we never make exceptions.

The “stress relief” reason: real or misleading?

A significant portion of UK vapers report stress relief or anxiety management as a reason for vaping. This deserves honest examination because the answer is mostly “misleading.” The mechanism most chronic vapers experience is withdrawal cycling. Chronic users develop nicotine dependence over weeks of regular use. Between vape sessions, nicotine plasma levels fall, triggering mild withdrawal symptoms (irritability, anxiety, tension, restlessness). Each vape session relieves this withdrawal, producing a “calm” feeling that the brain interprets as stress relief. But the calm is actually return-to-baseline from below-baseline withdrawal – not true stress reduction. UK Royal College of Psychiatrists: nicotine should not be used for anxiety management; the apparent benefit is withdrawal relief, not real treatment. Long-term, chronic nicotine users have elevated anxiety and depression rates compared with never-users (2-3x per UK research). Mental health typically improves within 3-6 months of cessation. NHS guidance: address anxiety with evidence-based treatments (CBT, SSRIs, mindfulness, exercise, sleep optimisation) rather than nicotine. ScienceInsights March 2026 article: “people who vape for stress relief face an added challenge: the anxiety they’re self-medicating often worsens with dependence, creating a feedback loop where the solution and the problem become the same thing.” For UK adults using vape for stress: consider whether the “relief” is real or withdrawal cycling. NHS IAPT (Improving Access to Psychological Therapies) self-referral provides free CBT for anxiety; combination with vape cessation often produces measurable mental health improvement.

For UK adults curious about why others vape, the five-reason summary below reflects ASH 2024 data and UK research.

For UK adults considering starting vape, the only NHS-endorsed reason is smoking cessation. UK Chief Medical Officer position: “if you smoke, vaping is much safer; if you do not smoke, do not vape.” For UK never-smokers considering vape for cost, flavour or social reasons: starting clinical nicotine dependence for these reasons is not medically recommended. Our Omagh and Strabane teams stock TPD-compliant products for UK adults using vape as smoking cessation or harm reduction; we provide age-verified sale to 18+ adults only and do not promote vape to never-smokers.